Pressmeddelanden
REG
Eevia has stopped the liquidity arrangement at Spotlight Stockmarket
Eevia Health Abp ("Eevia Health" or the "Company") has ended the arrangement with Mangold Fondkommission act as a liquidity provider for the company's shares at the Spotlight Sto...
Eevia Health secures an 868 KSEK sales order from a new customer for a new superior polyphenol extract
Eevia Health Plc ("Eevia" or "The Company") has won a 77 KEUR (868 KSEK) sales order from a new North American brand owner. The order is the first commercial customer for Feno-Ce...
REG
Communique from the Annual General Meeting in Eevia Health Plc 2024
The Annual General Meeting of Shareholders of Eevia Health Plc, corp. reg. no 2825194-4 (the "Company") was held on June 28, 2024, in Seinäjoki, Finland.
Eevia Health Plc receives a 578 KSEK (51 KEUR) sales order for a Bilberry extract product
Eevia Health Plc, ("Eevia" or "The Company"), has received a 51 KEUR sales order from a European nutraceutical brand owner.
REG
MAR
Eevia Health Plc enters a new stage in global sales project with an international market partner
Eevia Health Plc ("Eevia" or "The Company") has collaborated with a major international ingredient house over the last 12 months on possible commercial cooperation for the global...
REG
MAR
Eevia Health Plc partners up to enter 5-billion-euro eye-health market
Eevia Health Plc ("Eevia" or "The Company") received a letter of Intent with a global leader in eye health for a market launch in 2025 of Retinari™, a new game-changing eye-healt...
Rapporter
Video
Finansiell kalender
Delårsrapport Q2 2024
Delårsrapport
Om Eevia Health
Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.
Webbplats
eeviahealth.com/investors
Handelsinformation
Kurs ()
Förändring ()